设计下一代中级AMD临床试验 - - 一项以共识为导向,务实,概念验证的早期干预研究
Robyn H Guymer1, Philip J Rosenfeld2, Justis P Ehlers3
1Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia; Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Australia.
Experimental eye research
|March 16, 2025
概括
专家们提出了一个早期干预临床试验的框架,用于中期与年龄相关的黄斑退化 (AMD). 这种共识旨在加快开发缓慢AMD进展的治疗方法,在视力威胁的阶段之前.
科学领域:
- 眼科医生 眼科 眼科
- 临床试验设计 临床试验设计
- 与年龄相关的黄斑退化 (AMD) 研究
背景情况:
- 了解AMD病理生理学的进步使新的治疗策略成为可能.
- 结构成像和功能结果是AMD临床试验的关键替代终点.
- 早期干预现在对AMD是可行的,在临床试验时间框架中取得了可衡量的成功.
研究的目的:
- 建立一个共识框架,用于设计早期干预临床试验中期与年龄相关的黄斑退化症 (iAMD).
- 为24个月的早期干预试验提出一个假设的,务实的,概念验证的研究设计.
- 为治疗开发者和监管机构提供一个有用的文件.
主要方法:
- 在2024年瑞安黄斑研究倡议 (RIMR) 会议上达成共识.
- 共识的重点是设计一个假设的,务实的,概念验证,24个月的早期干预研究.
- 拟议的试验针对的是中级AMD (iAMD) 的受试者.
主要成果:
- 建立了早期AMD临床试验的共识框架.
- 提出了一个假设的24个月的研究设计,用于iAMD早期干预.
- 该框架旨在通过自然历史队列和干预试验验证试验设计和终点.
结论:
- 拟议的框架有助于开发缓慢AMD进展的治疗方法.
- 这种共识有助于设计AMD早期干预的临床试验.
- 目标是在视力威胁的晚期AMD出现之前减缓AMD的进展.
更多相关视频
09:46Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy
Published on: February 26, 2021
3.1K
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
3.0K
相关概念视频
iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.7K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.7K
